{"title":"STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials","path":"/2026/02/17/compass-pathways-comp360-psilocybin-severe-depression-trial-results/?utm_campaign=rss","site":"https://www.statnews.com","atUri":"at://did:plc:5ka4qkui7nvjms7idhte2m4o/site.standard.document/3mf4lnz4qkwx2","publishedAt":"2026-02-17T11:30:00Z","tags":"Biotech;Breaking News;Health;Pharma;biotechnology;drug development;Mental Health;Pharmaceuticals;Policy;psychedelics;STAT+"}